Results 51 to 60 of about 6,070 (214)
Case Report: MR-Guided Adaptive Radiotherapy, Some Room to Maneuver
BackgroundA magnetic resonance linear accelerator (MR-Linac) provides superior soft tissue contrast to evaluate inter- and intra-fraction motion and facilitate online adaptive radiation therapy (ART).
Winnie Li +9 more
doaj +1 more source
RF-signaalin siirtomenetelmiä vastaanottokeloille magneettikuvauslaitteen ja lineaarikiihdyttimen integraatiossa [PDF]
MR-Linac is an integration of a magnetic resonance imaging system and a linear accelerator. It is used to deliver image-guided radiation therapy treatments for patients with cancer.
Pusa, Jehki
core
The need for multidisciplinarity in specialist training to optimize future patient care [PDF]
Harmonious interactions between radiation, medical, interventional and surgical oncologists, as well as other members of multidisciplinary teams, are essential for the optimization of patient care in oncology.
A Adam +56 more
core +1 more source
This study evaluated four stereotactic radiosurgery planning approaches for posterior choroidal melanoma (CM). Analysis of thirteen CM cases resulted in a clinically meaningful reduction in dose to the brain for Brainlab Elements modulated arcs (BE) and Varian Eclipse HyperArc modulated arcs (HA) compared to Brainlab iPlan dynamic conformal arc therapy
Robert Nigro +5 more
wiley +1 more source
Background The aim of this study was to evaluate and compare the performance of intensity modulated radiation therapy (IMRT) plans, planned for low-field strength magnetic resonance (MR) guided linear accelerator (linac) delivery (labelled IMRT MRL plans)
Vanessa Da Silva Mendes +9 more
doaj +1 more source
Summary: The treatment of oligometastatic disease using MR guidance is an evolving field. Since August 2018 patients are treated on a 1.5 Tesla MR-Linac (MRL).
Tomas M. Janssen +14 more
doaj +1 more source
This review article reports that quantification of hypoxic volumes using PET in the pre‐radiation therapy setting is of prognostic value and indicative of treatment response in non‐small cell lung cancer. Abstract Introduction Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death. Definitive treatment includes chemotherapy and
Carol Marks, Michelle Leech
wiley +1 more source
Background and purpose: Magnetic resonance imaging – linear accelerator (MRI-linac) systems permit imaging of tumours to guide treatment. Dynamic contrast enhanced (DCE)-MRI allows investigation of tumour perfusion.
Michael J. Dubec +13 more
doaj +1 more source
Background The AGuIX® (NH TherAguix) nanoparticle has been developed to enhance radiotherapy treatment and provide strong MR contrast. These two properties have previously been investigated separately and progressed to clinical trial following a clinical
H. L. Byrne +10 more
doaj +1 more source
Spatiotemporal fractionation schemes, that is, treatments delivering different dose distributions in different fractions, may lower treatment side effects without compromising tumor control.
Gaddy, Melissa R. +3 more
core +1 more source

